Healthcare Experience

Brand Institute Healthcare Share of Market


Our Healthcare experience includes 708 clients, with 2,616 partnered brands and 632 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
4SC resminostat Oncology
ABBOTT LABORATORIES enavatuzumab Oncology
ABBVIE azintuxizumab Oncology
ABBVIE azintuxizumab vedotin Oncology
ABBVIE depatuxizumab Oncology
ABBVIE depatuxizumab mafodotin Oncology
ABBVIE elotuzumab Oncology
ABBVIE ilorasertib Oncology
ABBVIE linifanib Oncology
ABBVIE navitoclax Oncology
ABBVIE rizankizumab Oncology
ABBVIE telisotuzumab Oncology
ABBVIE telisotuzumab vedotin Oncology
ABBVIE veliparib Oncology
ABBVIE venetoclax Oncology
ACERTA PHARMA acalabrutinib Oncology
ACERTA PHARMA CALQUENCE * Oncology
ACETYLON ricolinostat Oncology
ADC THERAPEUTICS camidanlumab Oncology
ADC THERAPEUTICS camidanlumab tesirine Oncology
ADC THERAPEUTICS loncastuximab Oncology
ADC THERAPEUTICS loncastuximab tesirine Oncology
ADURO damistimagene matitucel Oncology
ADURO enistimagene setitucel Oncology
ADVAXIS axalimogene filolisbac Oncology
ADVAXIS capolimogene apralisbac Oncology
AEGELA BIOTHERAPEUTICS pegzilarginase Oncology
AGIOS enasidenib Oncology
AGIOS ivosidenib Oncology
AGIOS vorasidenib Oncology
AMGEN bevacizumab beta Oncology
AMGEN BLINCYTO * Oncology
AMGEN KYPROLIS * Oncology
AMGEN MVASI * Oncology
AMGEN oprozomib Oncology
AMGEN sitravatinib Oncology
AMGEN trebananib Oncology
AMGEN XGEVA Oncology
APOTEX docetaxel Oncology
ARIAD ALUNBRIG Oncology
ARIAD ICLUSIG Oncology
ARIAD ponatinib Oncology
ARIAD ponatinib hydrochloride Oncology
ARQULE derazantinib Oncology
ARQULE miransertib Oncology
ASTELLAS XTANDI Oncology
ASTELLAS zolbetuximab Oncology
ASTEX guadecitabine Oncology
ASTRAZENECA acalabrutinib Oncology
ASTRAZENECA adavosertib Oncology
ASTRAZENECA bicalutamide Oncology
ASTRAZENECA capivasertib Oncology
ASTRAZENECA CAPRELSA Oncology
ASTRAZENECA CASODEX Oncology
ASTRAZENECA CASODEX OD
(カソデックスOD)
Oncology
ASTRAZENECA danvatirsen Oncology
ASTRAZENECA FASLODEX * Oncology
ASTRAZENECA IRESSA * Oncology
ASTRAZENECA savolitinib Oncology
ASTRAZENECA selumetinib Oncology
ASTRAZENECA selumetinib sulfate Oncology
ASTRAZENECA TAGRISSO * Oncology
ASTRAZENECA ZOLADEX Oncology
ATRIX LABORATORIES ELIGARD * Oncology
BASILEA PHARMACEUTICALS lisavanbulin Oncology
BAYER ALIQOPA * Oncology
BAYER aprutumab Oncology
BAYER aprutumab ixadotin Oncology
BAYER copanlisib Oncology
BAYER darolutamide Oncology
BAYER NEXAVAR * Oncology
BAYER radretumab Oncology
BAYER refametinib Oncology
BAYER roniciclib Oncology
BAYER sorafenib Oncology
BAYER VIADUR Oncology
BAYER XOFIGO Oncology
BAYER XOFIGO (RADIUM RA 223 DICHLORIDE) Oncology
BEIGENE lifirafenib Oncology
BEIGENE pamiparib Oncology
BEIGENE tislelizumab Oncology
BEIGENE zanubrutinib Oncology
BELLICUM PHARMACEUTICALS rimiducid Oncology
BERGEN BIO bemcentinib Oncology
BIO-PATH HOLDINGS prexigebersen Oncology
BIOGEN RITUXAN Oncology
BIOMARIN talazoparib Oncology
BIOMED VALLEY ulixertinib Oncology
BIONUMERIK PHARMACEUTICALS TAVOCEPT Oncology
BIPAR iniparib Oncology
BLAZE BIOSCIENCE tozuleristide Oncology
BLUEPRINT MEDICINES avapritinib Oncology
BOEHRINGER INGELHEIM GILOTRIF Oncology
Bristol-Myers Squibb alvespimycin Oncology
Bristol-Myers Squibb alvespimycin hydrochloride Oncology
BRISTOL-MYERS SQUIBB TANESPIMYCIN Oncology
CANTEX PHARMACEUTICALS dociparstat Oncology
Cascadian Therapeutics sonolisib Oncology
Cascadian Therapeutics tucatinib Oncology
CASI PHARMACEUTICALS PANZEM Oncology
CASI PHARMACEUTICALS PROMUNE Oncology
CELATOR PHARMA VYXEOS * Oncology
CELGENE amrubicin hydrochloride Oncology
CELGENE ISTODAX * Oncology
CELGENE mocetinostat Oncology
CELGENE mocetinostat dihydrobromide Oncology
CELGENE pomalidomide Oncology
CELGENE vadacabtagene leraleucel Oncology
CELGENE VIDAZA Oncology
CELLTRION HEALTHCARE BLITZIMA Oncology
CELLTRION HEALTHCARE HERZUMA Oncology
CELLTRION HEALTHCARE RITEMVIA Oncology
CELLTRION HEALTHCARE TRUXIMA Oncology
CELLTRION HEALTHCARE TUXELLA Oncology
CEPHALON omacetaxine mepesuccinate Oncology
CEPHALON SYNRIBO * Oncology
CEPHALON TREANDA * Oncology
CEPTARIS THERAPEUTICS VALCHLOR * Oncology
CERULEAN davamotecan pegadexamer Oncology
CHUGAI PHARMA ALECENSA * Oncology
CLOVIS rociletinib Oncology
DAIICHI-SANKYO milademetan Oncology
DAIICHI-SANKYO patritumab Oncology
DAIICHI-SANKYO pexidartinib Oncology
DAIICHI-SANKYO tivantinib Oncology
DENDREON lapuleucel-t Oncology
DENDREON PROVENGE Oncology
DENDREON sipuleucel-t Oncology
DNATRIX THERAPEUTICS tasadenoturev Oncology
EAGLE PHARMACEUTICALS BENDEKA * Oncology
EISAI DACOGEN Oncology
EISAI HALAVEN Oncology
EISAI KISPLYX Oncology
EISAI LENVIMA Oncology
EMD SERONO evobrutinib Oncology
EPIZYME pinometostat Oncology
EPIZYME tazemetostat Oncology
ERIMOS PHARMACEUTICALS terameprocol Oncology
EUSA PHARMA QARZIBA Oncology
EXELIXIS cabozantinib Oncology
FIVE PRIME THERAPEUTICS bemarituzumab Oncology
FIVE PRIME THERAPEUTICS cabiralizumab Oncology
GENENTECH ALECENSA * Oncology
GENENTECH atezolizumab Oncology
GENENTECH AVASTIN * Oncology
GENENTECH cobimetinib Oncology
GENENTECH dulanermin Oncology
GENENTECH duligotuzumab Oncology
GENENTECH GAZYVA * Oncology
GENENTECH ipatasertib Oncology
GENENTECH KADCYLA (カドサイラ) Oncology
GENENTECH mosunetuzumab Oncology
GENENTECH PERJETA (パージェタ) * Oncology
GENENTECH pinatuzumab vedotin Oncology
GENENTECH polatuzumab vedotin Oncology
GENENTECH RITUXAN Oncology
GENENTECH TARCEVA * Oncology
GENENTECH taselisib Oncology
GENENTECH TECENTRIQ * Oncology
GENENTECH tiragolumab Oncology
GENEXINE tirvalimogene teraplasmid Oncology
GENMAB ARZERRA (アーゼラ) Oncology
GENOMIC HEALTH GENOMIC PROSTATE SCORE (GPS) Oncology
GENTA GENASENSE Oncology
GERON paclitaxel trevatide Oncology
GILEAD acalisib Oncology
GILEAD alobresib Oncology
GILEAD andecaliximab Oncology
GILEAD entospletinib Oncology
GILEAD idelalisib Oncology
GILEAD simtuzumab Oncology
GILEAD tirabrutinib Oncology
GILEAD vesatolimod Oncology
GLAXOSMITHKLINE ARZERRA (アーゼラ) Oncology
GLAXOSMITHKLINE astuprotimut-r Oncology
GLAXOSMITHKLINE BEXXAR * Oncology
GLAXOSMITHKLINE CYTEFURAN Oncology
GLAXOSMITHKLINE MEKINIST * Oncology
GLAXOSMITHKLINE molibresib Oncology
GLAXOSMITHKLINE omipalisib Oncology
GLAXOSMITHKLINE REZONIC Oncology
GLAXOSMITHKLINE TAFINLAR * Oncology
GLAXOSMITHKLINE uprosertib Oncology
GLAXOSMITHKLINE VOTRIENT * Oncology
GLAXOSMITHKLINE zastumotide Oncology
GLYCOTOPE gatipotuzumab Oncology
GLYCOTOPE timigutuzumab Oncology
GLYCOTOPE tomuzotuximab Oncology
HALOZYME THERAPEUTICS pegvorhyaluronidase alfa Oncology
HANMI PHARMACEUTICALS olmutinib Oncology
HANMI PHARMACEUTICALS poseltinib Oncology
HELSINN HEALTHCARE AMIXEA Oncology
HELSINN HEALTHCARE RESSURO Oncology
IDERA PHARMACEUTICALS tilsotolimod Oncology
IGNYTA entrectinib Oncology
IMMUNOGEN cantuzumab ravtansine Oncology
IMMUNOGEN laprituximab Oncology
IMMUNOGEN laprituximab emtansine Oncology
IMMUNOGEN lorvotuzumab mertansine Oncology
IMMUNOGEN mirvetuximab soravtansine Oncology
IMMUNOGEN naratuximab emtansine Oncology
INNOCRIN PHARMACEUTICALS seviteronel Oncology
INSPYR Therapeutics mipsagargin Oncology
INTREXON veledimex Oncology
INTROGEN THERAPEUTICS ADVEXIN * Oncology
IPR PHARMS CAPRELSA Oncology
ISOFOL arfolitixorin Oncology
ISOTECHNIKA terameprocol Oncology
JANSSEN apalutamide Oncology
JANSSEN daratumumab Oncology
JANSSEN DARZALEX Oncology
JANSSEN duvortuxizumab Oncology
JANSSEN ERLEADA Oncology
JANSSEN opolimogene capmilisbac Oncology
JANSSEN pemlimogene merolisbac Oncology
JANSSEN seltorexant Oncology
JANSSEN SYLVANT Oncology
JANSSEN talacotuzumab Oncology
JANSSEN YONDELIS * Oncology
JANSSEN ZYTIGA * Oncology
JAZZ PHARMACEUTICALS pegcrisantaspase Oncology
JENNEREX pexastimogene devacirepvec Oncology
JOHNSON & JOHNSON carlumab Oncology
JOHNSON & JOHNSON intetumumab Oncology
JOHNSON & JOHNSON quisinostat Oncology
JOHNSON & JOHNSON serdemetan Oncology
JOHNSON & JOHNSON siltuximab Oncology
JOHNSON & JOHNSON talmapimod Oncology
JUNO THERAPEUTICS vadacabtagene leraleucel Oncology
KARYOPHARM selinexor Oncology
KYOWA HAKKO KIRIN POTELIGEO Oncology
LIGAND PHARMACEUTICALS ONTAK Oncology
LIGAND PHARMACEUTICALS TARGRETIN * Oncology
LOXO ONCOLOGY larotrectinib Oncology
LSK BIOPHARMA rivoceranib Oncology
LUNDBECK INC. ingenol disoxate Oncology
LUNDBECK INC. TREANDA * Oncology
LUNDBECK INC. TRISENOX * Oncology
MAST THERAPEUTICS folitixorin Oncology
MAST THERAPEUTICS folitixorin calcium Oncology
MEDIMMUNE blinatumomab Oncology
MEDIMMUNE etaracizumab Oncology
MEDIMMUNE moxetumomab pasudotox Oncology
MEDIVATION enzalutamide Oncology
MEDIVATION XTANDI * Oncology
MERCK & CO. KEYTRUDA Oncology
MERCK & CO. pembrolizumab Oncology
MERCK & CO. SYLATRON Oncology
MERCK & CO. TEMODAR * Oncology
MERCK & CO. ZOLINZA Oncology
MIRATI THERAPEUTICS glesatinib Oncology
MOLOGEN lefitolimod Oncology
MUNDIPHARMA DIFOLTA Oncology
MUNDIPHARMA tinostamustine Oncology
MYRIAD verubulin Oncology
NANOCARRIER demplatin pegraglumer Oncology
NEKTAR etirinotecan pegol Oncology
NEKTAR etirinotecan pegol tetrahydrochloride Oncology
NEKTAR etirinotecan pegol tetratriflutate Oncology
NEOGENIX ONCOLOGY ensituximab Oncology
NEWRON XADAGO * Oncology
NIPPON KAYAKU firtecan peglumer Oncology
NOVARTIS AFINITOR Oncology
NOVARTIS AMDRAY * Oncology
NOVARTIS dovitinib Oncology
NOVARTIS dovitinib lactate Oncology
NOVARTIS FARYDAK * Oncology
NOVARTIS JAKAVI Oncology
NOVARTIS KYMRIAH Oncology
NOVARTIS lucatumumab Oncology
NOVARTIS ODOMZO Oncology
NOVARTIS RYDAPT Oncology
NOVARTIS TASIGNA Oncology
NOVARTIS tisagenlecleucel Oncology
NOVARTIS VOTUBIA Oncology
NOVARTIS ZOMETA * Oncology
NOVARTIS ZYKADIA * Oncology
OCTAPHARMA AB satoreotide Oncology
OCTREOPHARM satoreotide trizoxetan Oncology
ONCOMED brontictuzumab Oncology
ONCOMED demcizumab Oncology
ONCOMED ipafricept Oncology
ONCOMED navicixizumab Oncology
ONCOMED navicixizumab Oncology
ONCOMED rosmantuzumab Oncology
ONCOMED tarextumab Oncology
ONCOMED vantictumab Oncology
ONCOPEPTIDES melphalan flufenamide Oncology
ONCOTHERAPY SCIENCE elpamotide Oncology
ONCOTHERAPY SCIENCE latromotide Oncology
ONCOTHERAPY SCIENCE pradimotide Oncology
OSI PHARMACEUTICALS linsitinib Oncology
OSI PHARMACEUTICALS TARCEVA * Oncology
OXIGENE fosbretabulin Oncology
OXIGENE fosbretabulin disodium Oncology
OXIGENE fosbretabulin tromethamine Oncology
PENDOPHARM ZEULIDE DEPOT * Oncology
PFIZER agatolimod Oncology
PFIZER BESPONSA Oncology
PFIZER gemtuzumab ozogamicin Oncology
PFIZER IBRANCE Oncology
PFIZER METARET Oncology
PFIZER SYNTHOKINE Oncology
PFIZER TRELSTAR Oncology
PHARMACYCLICS abexinostat Oncology
PHARMACYCLICS ibrutinib Oncology
PHARMACYCLICS IMBRUVICA * Oncology
PIQUR bimiralisib Oncology
PORTOLA cerdulatinib Oncology
PUMA BIOTECHNOLOGY NERLYNX * Oncology
QLT USA ELIGARD Oncology
RADIUS HEALTH elacestrant Oncology
REGENERON PHARMACEUTICALS ZALTRAP Oncology
ROCHE ALECENSARO * Oncology
ROCHE GAZYVA * Oncology
ROCHE imgatuzumab Oncology
ROCHE KADCYLA (カドサイラ) Oncology
ROCHE TARCEVA * Oncology
ROCHE XELODA Oncology
SANDOZ RIXATHON Oncology
SANDOZ RIXIMYO Oncology
SANOFI ELIGARD Oncology
SANOFI ELITEK Oncology
SANOFI ELOXATIN Oncology
SANOFI fedratinib Oncology
SANOFI isatuximab Oncology
SANOFI JEVTANA * Oncology
SANOFI NILANDRON Oncology
SANOFI pilaralisib Oncology
SANOFI PLENAXIS * Oncology
SANOFI seribantumab Oncology
SANOFI TAXOTERE Oncology
SANOFI voxtalisib Oncology
SANOFI ZALTRAP Oncology
SEATTLE GENETICS ADCETRIS (アドセトリス) * Oncology
SEATTLE GENETICS denintuzumab mafodotin Oncology
SEATTLE GENETICS enfortumab vedotin Oncology
SEATTLE GENETICS ladiratuzumab Oncology
SEATTLE GENETICS ladiratuzumab vedotin Oncology
SEATTLE GENETICS vadastuximab Oncology
SEATTLE GENETICS vadastuximab talirine Oncology
SEATTLE GENETICS vorsetuzumab mafodotin Oncology
SHIONOGI PHARMA alicdamotide Oncology
SHIONOGI PHARMA asudemotide Oncology
SHIONOGI PHARMA epertinib Oncology
SHIONOGI PHARMA trempamotide Oncology
SHIRE PHARMACEUTICALS imalumab Oncology
SIEMENS flortanidazole (18f) Oncology
SIEMENS flotegatide (18f) Oncology
SPECTRUM PHARMACEUTICALS belinostat Oncology
SPECTRUM PHARMACEUTICALS BRAKIVA Oncology
SPECTRUM PHARMACEUTICALS FOLOTYN Oncology
SPECTRUM PHARMACEUTICALS FUSILEV Oncology
SPECTRUM PHARMACEUTICALS KYRBAX Oncology
SPECTRUM PHARMACEUTICALS MARQIBO Oncology
SPECTRUM PHARMACEUTICALS ZEVALIN Oncology
STEMCENTRX rovalpituzumab Oncology
STEMCENTRX rovalpituzumab tesirine Oncology
SUNESIS vecabrutinib Oncology
SUNESIS PHARMACEUTICALS QUINPREZO Oncology
SUNESIS PHARMACEUTICALS vosaroxin Oncology
SYNTA PHARMACEUTICALS elesclomol Oncology
SYNTA PHARMACEUTICALS rosabulin Oncology
TAIHO PHARMA LONSURF Oncology
TAIHO PHARMA TEYSUNO * Oncology
TAKARA BIO canerpaturev Oncology
TAKEDA PHARMACEUTICALS alisertib Oncology
TAKEDA PHARMACEUTICALS indusatumab Oncology
TAKEDA PHARMACEUTICALS indusatumab vedotin Oncology
TAKEDA PHARMACEUTICALS ixazomib Oncology
TAKEDA PHARMACEUTICALS NINLARO Oncology
TAKEDA PHARMACEUTICALS orteronel Oncology
TAKEDA PHARMACEUTICALS sapanisertib Oncology
TAKEDA PHARMACEUTICALS serabelisib Oncology
TAKEDA PHARMACEUTICALS VELCADE Oncology
TESARO belizatinib Oncology
TESARO ZEJULA Oncology
TEVA PHARMACEUTICAL INDUSTRIES BENDEKA * Oncology
THRESHOLD PHARMACEUTICALS tarloxotinib bromide Oncology
TRACON PHARMACEUTICALS carotuximab Oncology
TYROGENEX vorolanib Oncology
UNITED THERAPEUTICS UNITUXIN Oncology
VERTEX berzosertib Oncology
VION laromustine Oncology
XCOVERY ensartinib Oncology
YM BIOSCIENCES lexibulin Oncology
ZYMOGENETICS CERVATEC Oncology


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMA, and/or Health Canada, and other Regulatory Agencies.

Back to top